Original Article
The development and validation of pathological sections based U-Net deep learning segmentation model for the detection of esophageal mucosa and squamous cell neoplasm
Journal of Gastrointestinal Oncology
2023;
14
(5)
:1982-1992
.
(31 October 2023)
Feeding via duodenostomy can reduce intestinal obstruction after radical resection of esophageal cancer better than jejunostomy
Journal of Gastrointestinal Oncology
2023;
14
(5)
:1993-2005
.
(31 October 2023)
Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of raw Pinellia ternate in treating esophageal cancer
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2006-2017
.
(31 October 2023)
Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2018-2027
.
(31 October 2023)
The prognostic role of gastrointestinal bleeding in patients with a primary gastrointestinal stromal tumor: a long-term follow-up study
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2028-2038
.
(31 October 2023)
High albumin-bilirubin grade predicts worse short-term complications in gastric cancer patients with metabolic syndrome: a retrospective study
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2039-2047
.
(31 October 2023)
Radiomics based on machine learning algorithms could predict prognosis and postoperative chemotherapy benefits of patients with gastric cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2048-2063
.
(31 October 2023)
Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2064-2082
.
(31 October 2023)
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2083-2096
.
(31 October 2023)
Effect of human epidermal growth factor receptor 2 overexpression in metastatic colorectal cancer on standard chemotherapy outcomes
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2097-2110
.
(31 October 2023)
RRP12 suppresses cell migration and invasion in colorectal cancer cell via regulation of epithelial-mesenchymal transition
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2111-2123
.
(31 October 2023)
In vitro study of miRNA-369-3p targeting TCF4 regulating the malignant biological behavior of colon cancer cells
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2124-2133
.
(31 October 2023)
The relationship between GLIM-malnutrition, post-operative complications and long-term prognosis in elderly patients undergoing colorectal cancer surgery
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2134-2145
.
(31 October 2023)
Transmembrane serine protease 2, a SARS-CoV-2 internalization protease, correlates with clinical outcome, molecular features, and immunotherapy response in colorectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2146-2157
.
(31 October 2023)
Right hepatic artery anomalies in pancreatoduodenectomy—a risk for arterial resection but not for postoperative outcomes
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2158-2166
.
(31 October 2023)
Comparison of transarterial bland embolization and drug-eluting beads transarterial chemoembolization for very early and early hepatocellular carcinoma not amenable for surgery or ablation: a single center retrospective data analysis
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2167-2177
.
(31 October 2023)
HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2178-2191
.
(31 October 2023)
Evaluation of the serotonin pathway as a biomarker in cholangiocarcinoma
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2192-2201
.
(31 October 2023)
Intrahepatic cholangiocarcinoma: a dose threshold evaluation in those undergoing transarterial radioembolization
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2202-2211
.
(31 October 2023)
Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2212-2220
.
(31 October 2023)
Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2221-2228
.
(31 October 2023)
Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2229-2242
.
(31 October 2023)
Review Article
Surgical considerations for the “perfect” colorectal anastomosis
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2243-2248
.
(31 October 2023)
Detection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2249-2259
.
(31 October 2023)
A narrative review of imaging for pancreas adenocarcinoma: staging, surgical considerations, and surveillance
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2260-2272
.
(31 October 2023)
Case Report
Near 5-year survival in metastatic pancreatic cancer patient with ROS1 rearrangement, HER2 amplification, and KRAS G12C mutation—a case report
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2273-2278
.
(31 October 2023)
Letter to the Editor
Prediction of early recurrence in patients with colorectal liver metastases
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2279-2281
.
(31 October 2023)
Editorial
Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2282-2286
.
(31 October 2023)
Total neoadjuvant therapy for locally advanced gastric cancer: too much of a good thing?
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2287-2289
.
(31 October 2023)
Determinants of gemcitabine response in pancreatic cancer: are we there?
Journal of Gastrointestinal Oncology
2023;
14
(5)
:2290-2292
.
(31 October 2023)
